XPK

TransMed7, LLC Announces First Clinical Use of Heron Soft Tissue Biopsy Devices for Commercial Launch

Retrieved on: 
Tuesday, August 16, 2022

The whole biopsy procedure was finished in less than 5 minutes, which represents a significant cost savings as well.

Key Points: 
  • The whole biopsy procedure was finished in less than 5 minutes, which represents a significant cost savings as well.
  • The Heron platform of soft tissue biopsy devices includes three models of hand-held, ultrasound guided, vacuum assisted, full fluid management, SIMC devices.
  • The Heron XPK and XPS full featured models are designed for manual coring length control and automatic tissue transport.
  • The Heron platform devices will provide the most advanced capabilities for biopsy devices featuring needle sizes from 12 to 18 gauge.